Axa
CELG

Axa’s Celgene Corp CELG Stock Holding History

Axa’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-205,758
Closed -$20.4M – 1386
2019
Q3 		$20.4M Sell
205,758
-429,677
-68% -$40.8M 0.08% 293
2019
Q2 		$58.7M Sell
635,435
-112,063
-15% -$10.6M 0.23% 122
2019
Q1 		$70.5M Sell
747,498
-370,423
-33% -$32.4M 0.28% 99
2018
Q4 		$71.6M Sell
1,117,921
-6,620
-0.6% -$489K 0.31% 84
2018
Q3 		$101M Sell
1,124,541
-213,526
-16% -$18.9M 0.37% 64
2018
Q2 		$106M Buy
1,338,067
+102,866
+8% +$8.54M 0.41% 55
2018
Q1 		$110M Buy
1,235,201
+74,449
+6% +$7.15M 0.44% 53
2017
Q4 		$121M Sell
1,160,752
-13,727
-1% -$1.55M 0.48% 39
2017
Q3 		$171M Sell
1,174,479
-80,935
-6% -$11M 0.74% 15
2017
Q2 		$163M Sell
1,255,414
-92,396
-7% -$11.3M 0.74% 20
2017
Q1 		$168M Sell
1,347,810
-248,701
-16% -$29.8M 0.76% 18
2016
Q4 		$185M Sell
1,596,511
-26,619
-2% -$2.96M 0.87% 11
2016
Q3 		$170M Sell
1,623,130
-32,389
-2% -$3.51M 0.75% 18
2016
Q2 		$163M Buy
1,655,519
+20,742
+1% +$2.15M 0.73% 19
2016
Q1 		$164M Sell
1,634,777
-360,041
-18% -$37.1M 0.73% 19
2015
Q4 		$239M Buy
1,994,818
+78,990
+4% +$9.14M 1.04% 7
2015
Q3 		$207M Buy
1,915,828
+14,469
+0.8% +$1.8M 0.85% 15
2015
Q2 		$220M Buy
1,901,359
+282,144
+17% +$32.3M 0.88% 13
2015
Q1 		$187M Buy
1,619,215
+96,318
+6% +$11.5M 0.77% 15
2014
Q4 		$170M Sell
1,522,897
-51,541
-3% -$5.44M 0.68% 24
2014
Q3 		$149M Sell
1,574,438
-94,412
-6% -$8.52M 0.64% 30
2014
Q2 		$143M Sell
1,668,850
-42,970
-3% -$3.27M 0.6% 36
2014
Q1 		$119M Buy
1,711,820
+289,904
+20% +$23M 0.52% 40
2013
Q4 		$120M Sell
1,421,916
-2,888
-0.2% -$229K 0.54% 36
2013
Q3 		$110M Buy
1,424,804
+51,778
+4% +$3.63M 0.54% 39
2013
Q2 		$80.3M Buy
+1,373,026
New +$82.6M 0.43% 54

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Axa's CELG Position: Q4 2019 in Review

Axa sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 205,758 shares — an estimated $20.4M sold.

Axa first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $239M in Q4 2015. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Axa reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Axa sold 205,758 Celgene Corp shares in Q4 2019, an estimated $20.4M.
  • Axa first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Axa's Celgene Corp position peaked at $239M in Q4 2015.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Axa's 13F filing for Q4 2019, filed 18 Feb 2020.